Alobaidi Ahmed, Albadry Ahmed, Murray Anne
Internal Medicine, Methodist Health System, Dallas, USA.
Faculty of Medicine, Charles University in Prague, Prague, CZE.
Cureus. 2023 Sep 22;15(9):e45750. doi: 10.7759/cureus.45750. eCollection 2023 Sep.
Aplastic anemia (AA) is a hematopoietic stem cell (HSC) disorder characterized by the loss of HSCs, bone marrow failure, and peripheral pancytopenia. AA is classified as very severe (VSAA), severe (SAA), or non-severe (NSAA) based on the severity criteria. This classification system has implications for the prognosis and treatment options offered to patients. The prognosis of AA has improved over the past several decades with the advancements in supportive care, HSC transplant (HCT), and immunosuppressive therapy (IST). In this report, we present the case of a 26-year-old male diagnosed with VSAA after presenting with severe neutropenia and fever. The patient ultimately underwent HSC transplantation.
再生障碍性贫血(AA)是一种造血干细胞(HSC)疾病,其特征为造血干细胞丧失、骨髓衰竭和外周血全血细胞减少。根据严重程度标准,AA分为极重型(VSAA)、重型(SAA)或非重型(NSAA)。该分类系统对患者的预后和治疗选择具有影响。随着支持治疗、造血干细胞移植(HCT)和免疫抑制治疗(IST)的进展,AA的预后在过去几十年中有所改善。在本报告中,我们介绍了一名26岁男性的病例,该患者在出现严重中性粒细胞减少和发热后被诊断为VSAA。患者最终接受了造血干细胞移植。